Skip to main content
COMPUGEN LTD logo

COMPUGEN LTD — Investor Relations & Filings

Ticker · CGEN US Professional, scientific and technical activities
Filings indexed 556 across all filing types
Latest filing 2024-03-05 Annual Report
Country US United States of America
Listing US CGEN

About COMPUGEN LTD

https://cgen.com/

Compugen Ltd. is a clinical-stage therapeutic discovery and development company focused on cancer immunotherapy. The company utilizes a proprietary, predictive computational platform powered by artificial intelligence and machine learning to systematically identify novel drug targets and biological pathways. This technology enables the discovery and development of first-in-class and best-in-class therapeutics. Compugen's pipeline consists of immuno-oncology programs, including antibody-based product candidates, which are advanced through preclinical and clinical development stages.

Recent filings

Filing Released Lang Actions
20-F
Annual Report FY 2023
2024-03-05 English
6-K
Foreign Filer Report
2024-03-05 English
6-K
Foreign Filer Report
2024-02-15 English
6-K
Foreign Filer Report
2024-01-08 English
6-K
Foreign Filer Report
2023-12-19 English
6-K
Foreign Filer Report
2023-11-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.